Skip to main content
Top
Published in: Journal of Genetic Counseling 6/2016

Open Access 01-12-2016 | Professional Issues

Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool

Authors: Lauren T. Garrett, Nathan Hickman, Angela Jacobson, Robin L. Bennett, Laura M. Amendola, Elisabeth A. Rosenthal, Brian H. Shirts

Published in: Journal of Genetic Counseling | Issue 6/2016

Login to get access

Abstract

Multi-gene cancer panels often identify variants of uncertain clinical significance (VUS) that pose a challenge to health care providers in managing a patient’s cancer risk. Family segregation analysis can yield powerful data to re-classify a VUS (as either benign or pathogenic). However, financial and personnel resources to coordinate these studies are limited. In an informal assessment we found that family studies for variant classification are done by most clinical genetics laboratories that offer hereditary cancer panel testing. The process for family studies differs substantially across laboratories. One near universal limitation is that families usually have too few individuals for an informative co-segregation analysis. A unique and potential resource-saving approach is to engage patients and their families in expanding their own pedigrees for segregation analysis of their VUS. We describe a novel public educational tool (FindMyVariant.​org) designed to inform patients and genetic counselors about strategies to improve the probability of variant classification using familial segregation. While the web tool is designed to be useful for any gene, the project was primarily focused on VUS’s returned in cancer risk genes. FindMyVariant.​org is a resource for genetic providers to offer motivated families who are willing to gather information about their family relationships and history. Working alongside clinical or research genetic laboratories, the information they collect may help reclassify their VUS using segregation analysis.
Literature
go back to reference Chambers, C., Jansen, L. A., & Dhamija, R. (2016). Review of commercially available epilepsy genetic panels. Journal of Genetic Counseling, 25(2), 213–217. doi:10.1007/s10897-015-9906-9. Chambers, C., Jansen, L. A., & Dhamija, R. (2016). Review of commercially available epilepsy genetic panels. Journal of Genetic Counseling, 25(2), 213–217. doi:10.​1007/​s10897-015-9906-9.
go back to reference Cragun, D., Radford, C., Dolinsky, J. S., Caldwell, M., Chao, E., & Pal, T. (2014). Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory. Clinical Genetics. doi:10.1111/cge.12359. Cragun, D., Radford, C., Dolinsky, J. S., Caldwell, M., Chao, E., & Pal, T. (2014). Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory. Clinical Genetics. doi:10.​1111/​cge.​12359.
go back to reference Culver, J., Brinkerhoff, C., Clague, J., Yang, K., Singh, K., Sand, S., & Weitzel, J. (2013). Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress. Clinical Genetics, 17(10), 12097. doi:10.1111/cge. Culver, J., Brinkerhoff, C., Clague, J., Yang, K., Singh, K., Sand, S., & Weitzel, J. (2013). Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress. Clinical Genetics, 17(10), 12097. doi:10.​1111/​cge.​
go back to reference Eggington, J. M., Bowles, K. R., Moyes, K., Manley, S., Esterling, L., Sizemore, S.,... Wenstrup, R. J. (2013). A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clinical Genetics, 8(10), 12315. Eggington, J. M., Bowles, K. R., Moyes, K., Manley, S., Esterling, L., Sizemore, S.,... Wenstrup, R. J. (2013). A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clinical Genetics, 8(10), 12315.
go back to reference Falk, M. J., Pierce, E. A., Consugar, M., Xie, M. H., Guadalupe, M., Hardy, O.,... Gai, X. (2012). Mitochondrial disease genetic diagnostics: optimized whole-exome analysis for all MitoCarta nuclear genes and the mitochondrial genome. Discovery Medicine, 14(79), 389–399. Falk, M. J., Pierce, E. A., Consugar, M., Xie, M. H., Guadalupe, M., Hardy, O.,... Gai, X. (2012). Mitochondrial disease genetic diagnostics: optimized whole-exome analysis for all MitoCarta nuclear genes and the mitochondrial genome. Discovery Medicine, 14(79), 389–399.
go back to reference Gallego, C. J., Shirts, B. H., Bennette, C. S., Guzauskas, G., Amendola, L. M., Horike-Pyne, M.,. .. Veenstra, D. L. (2015). Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: A Cost-Effectiveness Analysis. Journal of Clinical Oncology, 33(18), 2084–91. doi:10.1200/JCO.2014.59.3665. Gallego, C. J., Shirts, B. H., Bennette, C. S., Guzauskas, G., Amendola, L. M., Horike-Pyne, M.,. .. Veenstra, D. L. (2015). Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: A Cost-Effectiveness Analysis. Journal of Clinical Oncology, 33(18), 2084–91. doi:10.​1200/​JCO.​2014.​59.​3665.
go back to reference Goldgar, D. E., Easton, D. F., Byrnes, G. B., Spurdle, A. B., Iversen, E. S., & Greenblatt, M. S. (2008). Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Human Mutation, 29(11), 1265–1272. doi:10.1002/humu.20897.CrossRefPubMedPubMedCentral Goldgar, D. E., Easton, D. F., Byrnes, G. B., Spurdle, A. B., Iversen, E. S., & Greenblatt, M. S. (2008). Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Human Mutation, 29(11), 1265–1272. doi:10.​1002/​humu.​20897.CrossRefPubMedPubMedCentral
go back to reference Green, A., Green, H., Rehnberg, M., Svensson, A., Gunnarsson, C., & Jonasson, J. (2015). Assessment of HaloPlex amplification for sequence capture and massively parallel sequencing of arrhythmogenic right ventricular cardiomyopathy-associated genes. The Journal of Molecular Diagnostics, 17(1), 31–42. doi:10.1016/j.jmoldx.2014.09.006.CrossRefPubMed Green, A., Green, H., Rehnberg, M., Svensson, A., Gunnarsson, C., & Jonasson, J. (2015). Assessment of HaloPlex amplification for sequence capture and massively parallel sequencing of arrhythmogenic right ventricular cardiomyopathy-associated genes. The Journal of Molecular Diagnostics, 17(1), 31–42. doi:10.​1016/​j.​jmoldx.​2014.​09.​006.CrossRefPubMed
go back to reference Hunter, A. G., Graham Jr., J. M., Neri, G., Rogers, R. C., Stevenson, R. E., Turner, G., & Friez, M. J. (2014). The intellectual disabilities evaluation and advice system (IDEAS): outcome of the first 55 cases. American Journal of Medical Genetics. Part A, 164A(5), 1102–1117. doi:10.1002/ajmg.a.36456.CrossRefPubMed Hunter, A. G., Graham Jr., J. M., Neri, G., Rogers, R. C., Stevenson, R. E., Turner, G., & Friez, M. J. (2014). The intellectual disabilities evaluation and advice system (IDEAS): outcome of the first 55 cases. American Journal of Medical Genetics. Part A, 164A(5), 1102–1117. doi:10.​1002/​ajmg.​a.​36456.CrossRefPubMed
go back to reference Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S.,. .. Ford, J. M. (2014). Clinical evaluation of a multiple-Gene sequencing panel for hereditary cancer risk assessment. Journal of Clinical Oncology, 14, 14. Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S.,. .. Ford, J. M. (2014). Clinical evaluation of a multiple-Gene sequencing panel for hereditary cancer risk assessment. Journal of Clinical Oncology, 14, 14.
go back to reference Lek, M., Karczewski, K., Minikel, E., Samocha, K., Banks, E., Fennell, T.,. .. MacArthur, D. (2015). Analysis of protein-coding genetic variation in 60,706 humans. Biorxiv. doi:10.1101/030338. Lek, M., Karczewski, K., Minikel, E., Samocha, K., Banks, E., Fennell, T.,. .. MacArthur, D. (2015). Analysis of protein-coding genetic variation in 60,706 humans. Biorxiv. doi:10.​1101/​030338.​
go back to reference Lindor, N. M., Guidugli, L., Wang, X., Vallee, M. P., Monteiro, A. N., Tavtigian, S.,... Couch, F. J. (2012). A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Human Mutation, 33(1), 8–21. doi:10.1002/humu.21627. CrossRefPubMed Lindor, N. M., Guidugli, L., Wang, X., Vallee, M. P., Monteiro, A. N., Tavtigian, S.,... Couch, F. J. (2012). A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Human Mutation, 33(1), 8–21. doi:10.​1002/​humu.​21627.​ CrossRefPubMed
go back to reference Maxwell, K. N., Wubbenhorst, B., D’Andrea, K., Garman, B., Long, J. M., Powers, J.,. .. Nathanson, K. L. (2014). Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. Genetics in Medicine, 11(10), 176. doi:10.1038/gim.2014. Maxwell, K. N., Wubbenhorst, B., D’Andrea, K., Garman, B., Long, J. M., Powers, J.,. .. Nathanson, K. L. (2014). Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. Genetics in Medicine, 11(10), 176. doi:10.​1038/​gim.​2014.​
go back to reference Moghadasi, S., Hofland, N., Wouts, J. N., Hogervorst, F. B., Wijnen, J. T., Vreeswijk, M. P., & van Asperen, C. J. (2013). Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling. Journal of Medical Genetics, 50(2), 74–79. doi:10.1136/jmedgenet-2012-100961.CrossRefPubMed Moghadasi, S., Hofland, N., Wouts, J. N., Hogervorst, F. B., Wijnen, J. T., Vreeswijk, M. P., & van Asperen, C. J. (2013). Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling. Journal of Medical Genetics, 50(2), 74–79. doi:10.​1136/​jmedgenet-2012-100961.CrossRefPubMed
go back to reference Mohammadi, L., Vreeswijk, M. P., Oldenburg, R., van den Ouweland, A., Oosterwijk, J. C., van der Hout, A. H.,. .. van Houwelingen, H. C. (2009). A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example. BMC Cancer, 9(211). doi:10.1186/1471-2407-9-211. Mohammadi, L., Vreeswijk, M. P., Oldenburg, R., van den Ouweland, A., Oosterwijk, J. C., van der Hout, A. H.,. .. van Houwelingen, H. C. (2009). A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example. BMC Cancer, 9(211). doi:10.​1186/​1471-2407-9-211.​
go back to reference Murray, M. L., Cerrato, F., Bennett, R. L., & Jarvik, G. P. (2011). Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genetics in Medicine, 13(12), 998–1005. doi:10.1097/GIM.0b013e318226fc15. Murray, M. L., Cerrato, F., Bennett, R. L., & Jarvik, G. P. (2011). Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genetics in Medicine, 13(12), 998–1005. doi:10.​1097/​GIM.​0b013e318226fc15​.​
go back to reference O’Neill, S. C., DeMarco, T., Peshkin, B. N., Rogers, S., Rispoli, J., Brown, K.,. .. Schwartz, M. D. (2006). Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 142C(4), 251–259.CrossRefPubMed O’Neill, S. C., DeMarco, T., Peshkin, B. N., Rogers, S., Rispoli, J., Brown, K.,. .. Schwartz, M. D. (2006). Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 142C(4), 251–259.CrossRefPubMed
go back to reference Pritchard, C. C., Salipante, S. J., Koehler, K., Smith, C., Scroggins, S., Wood, B.,. .. Walsh, T. (2014). Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens. The Journal of Molecular Diagnostics, 16(1), 56–67. doi:10.1016/j.jmoldx.2013.08.004. CrossRefPubMedPubMedCentral Pritchard, C. C., Salipante, S. J., Koehler, K., Smith, C., Scroggins, S., Wood, B.,. .. Walsh, T. (2014). Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens. The Journal of Molecular Diagnostics, 16(1), 56–67. doi:10.​1016/​j.​jmoldx.​2013.​08.​004.​ CrossRefPubMedPubMedCentral
go back to reference Schulz, W. L., Tormey, C. A., & Torres, R. (2015). Computational approach to annotating variants of unknown significance in clinical next generation sequencing. ,Laboratoriums Medizin 46(4), 285–289. doi:10.1309/LMWZH57BRWOPR5RQ. Schulz, W. L., Tormey, C. A., & Torres, R. (2015). Computational approach to annotating variants of unknown significance in clinical next generation sequencing. ,Laboratoriums Medizin 46(4), 285–289. doi:10.​1309/​LMWZH57BRWOPR5RQ​.​
go back to reference Shirts, B. H., & Rosenthal, E. (2015, Oct 9, 2015). Power of Single Extended Pedigrees to Classify Rare Variants of Uncertain Significance in BRCA1 and BRCA2. Paper presented at the American Society of Human Genetics 65th Annual Meeting, Baltimore, MD. Shirts, B. H., & Rosenthal, E. (2015, Oct 9, 2015). Power of Single Extended Pedigrees to Classify Rare Variants of Uncertain Significance in BRCA1 and BRCA2. Paper presented at the American Society of Human Genetics 65th Annual Meeting, Baltimore, MD.
go back to reference Shirts, B. H., Jacobson, A., Jarvik, G. P., & Browning, B. L. (2013). Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes. Genetics in Medicine, 19(10), 187. doi:10.1038/gim.2013.187. Shirts, B. H., Jacobson, A., Jarvik, G. P., & Browning, B. L. (2013). Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes. Genetics in Medicine, 19(10), 187. doi:10.​1038/​gim.​2013.​187.
go back to reference Tung, N., Battelli, C., Allen, B., Kaldate, R., Bhatnagar, S., Bowles, K.,. .. Hartman, A. R. (2014). Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer, 3(10), 29010. Tung, N., Battelli, C., Allen, B., Kaldate, R., Bhatnagar, S., Bowles, K.,. .. Hartman, A. R. (2014). Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer, 3(10), 29010.
go back to reference van Dijk, S., Timmermans, D. R., Meijers-Heijboer, H., Tibben, A., van Asperen, C. J., & Otten, W. (2006). Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. Journal of Clinical Oncology, 24(22), 3672–3677.CrossRefPubMed van Dijk, S., Timmermans, D. R., Meijers-Heijboer, H., Tibben, A., van Asperen, C. J., & Otten, W. (2006). Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. Journal of Clinical Oncology, 24(22), 3672–3677.CrossRefPubMed
go back to reference Vos, J., Otten, W., van Asperen, C., Jansen, A., Menko, F., & Tibben, A. (2008). The counsellees’ view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life. Psychooncology., 17(8), 822–830.CrossRefPubMed Vos, J., Otten, W., van Asperen, C., Jansen, A., Menko, F., & Tibben, A. (2008). The counsellees’ view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life. Psychooncology., 17(8), 822–830.CrossRefPubMed
go back to reference Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M.,. .. Swisher, E. M. (2011). Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proceedings of the National Academy of Sciences of the United States of America, 108(44), 18032–18037. doi:10.1073/pnas.1115052108. CrossRefPubMedPubMedCentral Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M.,. .. Swisher, E. M. (2011). Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proceedings of the National Academy of Sciences of the United States of America, 108(44), 18032–18037. doi:10.​1073/​pnas.​1115052108.​ CrossRefPubMedPubMedCentral
Metadata
Title
Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool
Authors
Lauren T. Garrett
Nathan Hickman
Angela Jacobson
Robin L. Bennett
Laura M. Amendola
Elisabeth A. Rosenthal
Brian H. Shirts
Publication date
01-12-2016
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 6/2016
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-016-9993-2

Other articles of this Issue 6/2016

Journal of Genetic Counseling 6/2016 Go to the issue